The safety and efficacy of this drug for the treatment of constipation was demonstrated in clinical trials, and in 2006, the FDA approved lubiprostone (Amitiza ®, Sucampo Pharmaceuticals ...
You might be tempted to rush to a doctor for a prescription medication when you're dealing with nagging knee pain, a couple of days and nights of heartburn, or the misery of a migraine. But for ...
Central Nervous system - Headache, and dizziness. Lubiprostone(Amitiza) generic is a chloride channel activator, prescribed for chronic constipation and irritable bowel syndrome. It increases the ...
U.S. GAAP gross profit is calculated as total revenues less U.S. GAAP cost of sales. U.S. GAAP gross margin is calculated as U.S. GAAP gross profit divided by total revenues. Adjusted gross profit ...
Achieves First Quarter Net Sales of $467.8 Million, Reflecting 10.2% Year-Over-Year Growth on a Reported and Constant Currency Basis Reports Net Loss of $65.4 Million, Reflecting a 73.8% Year ...
Ion channels represent an important class of druggable targets; however, it is generally appreciated in the field that ion-channel targeted drug discovery has been hampered by the unavailability ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Sales in JANZ have likely witnessed a decline due to pricing dynamics partially offset by volume growth from three brands — Amitiza, Creon and Effexor. The Zacks Consensus Estimate for revenues ...
U.S. GAAP gross profit is calculated as total revenues less U.S. GAAP cost of sales. U.S. GAAP gross margin is calculated as U.S. GAAP gross profit divided by total revenues. Adjusted gross profit is ...
Q1 results are likely to gain from momentum in its branded and incremental revenues from new product launches.
Viatris Inc. (NASDAQ: VTRS) today announced its financial results for the first quarter of 2024, which reflect continued momentum and the strength of its base business. Executive Commentary ...